Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Result of AGM

14th Sep 2023 16:26

RNS Number : 5075M

Belluscura PLC

14 September 2023

Belluscura plc

("BELL" or the "Company")

Result of AGM

Belluscura plc (AIM: BELL) announces that at the Annual General Meeting ("AGM") held earlier today all the resolutions put to the meeting were duly approved by shareholders:

Resolution (*indicates special resolution)	Votes for	% of shares voted	Votes against	% of shares voted	Votes withheld
Resolution 1: To receive and adopt the report of the directors and the audited accounts of the Company for the period ended 31 December 2022	52,474,602	99.67%	175,911	0.33%	0
Resolution 2: To re-elect Mr David Poutney as a director of the Company.	52,471,268	99.67%	175,911	0.33%	3,334
Resolution 3. To re-elect Dr Patrick Strollo as a director of the Company.	52,628,453	99.96%	22,060	0.04%	0
Resolution 4: To re-appoint Gerald Edelman LLP as auditors.	52,628,453	99.96%	22,060	0.04%	0
Resolution 5: To authorise the directors to determine the remuneration of the auditors.	52,628,453	99.96%	22,060	0.04%	0
Resolution 6: To grant the directors authority to allot shares pursuant to Section 551 of the Companies Act 2006 and grant rights to subscribe for, or convert any security into, shares.	52,601,892	99.91%	48,621	0.09%	0
Resolution 7*: To dis-apply pre-emption rights pursuant to Section 570 of the Companies Act 2006.	52,601,892	99.91%	48,621	0.09%	0
Resolution 8*: To authorise the directors to make market purchases.	52,640,513	99.98%	10,000	0.02%	0

*Special resolutions

For further information please contact:

Belluscura plc	Tel: +44 (0)20 3128 8100
Adam Reynolds, ChairmanRobert Rauker, Chief Executive OfficerAnthony Dyer, Chief Financial Officer

SPARK Advisory Partners Limited Nominated Adviser	Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat

Dowgate Capital Limited Broker	Tel: +44 (0)20 3903 7715
James Serjeant / Russell Cook

MHP Financial PR & Investor Relations	Tel: +44 (0)20 3128 8100 email: [email protected]
Katie Hunt / Matthew Taylor

About Belluscura plc (www.belluscura.com)

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGZZGMLKDFGFZM

Related Shares:

FTSE 100 Latest

Value8,834.59

Change-36.72